nav-left cat-right
cat-right

Enzymes in Drug Discovery Summit February 29 ̵...

We are excited to announce the Enzymes in Drug Discovery Summit, which will take place February 29 – March 2, 2016 in San Diego, CA. Enzymes have proven to be an important group of drug targets in diseases, and enzyme inhibitors have been among the most successful of drugs. Join us as we discuss ways to overcome drug resistance to these inhibitors, and discuss breakthroughs in targeting historically undruggable...

Society of Toxicology Annual Meeting & ToxExp...

The SOT Annual Meeting is the largest meeting of its kind. This annual event features a broad range of scientific sessions and a thematic program that provides partici-pants with a unique opportunity to deepen their knowledge in topical areas and interact with leaders in their respective disciplines. The scientific program includes a plenary session, the MRC Lecture, symposia, work-shops, roundtable discussions, informational...

The Market for Therapeutic Biologicals is Evolving...

The Convergence of New Biologicals and the Growth of Biosimilars Will Require Changes at FDA according to Greystone Research Associates (Amherst, NH) – Activity in the biological drug sector is set to escalate, as a growing number of drug candidates reach the market and the number of applications requesting marketing authorization for biosimilars increases to a level that will force the FDA to institute new review...

Researchers create protein with potential for weig...

It sounds like a magic bullet: Administer a protein, watch the subject lose weight. But that’s exactly what University of Florida scientists found when they discovered a new way to deliver a protein that helps develop cells that convert fat into energy. The study builds upon on a discovery by Bruce Spiegelman, a cell biologist at the Boston-based Dana-Farber Cancer Institute, who found that human muscles release a hormone...

Illuminate key structure in heart cells

After a decade of debate, scientists have a clear picture of a controversial protein that helps regulate heart contractions. Brandeis University researchers have unlocked a controversial structure in heart cells responsible for regulating heart contractions. For years, scientists have debated how many KCNE1 proteins are required to build a potassium ion channel, theorizing anywhere between one and 14. Now, Brandeis University...

Epilepsy drug reverses fatty liver disease in obes...

A commonly used epilepsy drug may be able to stop fatty liver disease and prevent Type 2 diabetes in obese people, according to a new study by Johns Hopkins researchers. Scientists found that valproic acid, an anticonvulsant and mood-stabilizing drug prescribed to epilepsy patients, reduced fat accumulation in the liver and lowered blood sugar levels in obese mice. Obesity and a high-fat diet is often associated with the...
Page 1 of 212